Skip to main content
. 2019 Sep 27;11:8765–8780. doi: 10.2147/CMAR.S211603

Table 3.

Univariate Analysis And Multivariate Analysis Of The Risk Of Postoperative Complication In Young Patients And Elderly Patients

Factors Young Patients (<60y) Elderly patients (≥60y)
Non-PC Group 242(%) PC Group 52(%) Univariate p Multivariate p Non-PC Group 394(%) PC Group 154(%) Univariate p Multivariate p
Gender 0.883 0.192
 Male 165(68.2) 36(69.2) 312(79.2) 114(74.0)
 Female 77(31.8) 16(30.8) 82(20.8) 40(26.0)
BMI (kg/m2) 0.083 0.995
 <23.9 194(80.2) 36(69.2) 302(76.6) 118(76.6)
 ≥23.9 48(19.8) 16(30.8) 92(23.4) 36(23.4)
Charison score 0.001* 0.150
 0(0) 122(50.4) 31(59.6) 120(30.5) 40(26.0)
 1(1–3) 98(40.5) 9(17.3) 196(49.7) 72(46.8)
 2(4–6) 22(9.1) 12(23.1) 78(19.8) 42(27.2)
Preoperative anemia 0.247 0.421
 No 229(94.6) 47(90.4) 357(90.6) 136(88.3)
 Yes 13(5.4) 5(9.6) 37(9.4) 18(11.7)
Preoperative bleeding
 No
 Yes

234(96.7)
8(3.3)

49(94.2)
3(5.8)
0.396
378(95.9)
16(4.1)

147(95.5)
7(4.5)
0.799
Preoperative obstruction
 No
 Yes

234(96.7)
8(3.3)

51(98.1)
1(1.9)
0.599
379(96.2)
15(3.8)

147(95.5)
7(4.5)
0.692
Hypertension
 No
 Yes

208(86.0)
34(14.0)

44(84.6)
8(15.4)
0.803
260(66.0)
134(34.0)

104(67.5)
50(32.5)
0.731
Diabetes
 No
 Yes

229(94.6)
13(5.4)

49(94.2)
3(5.8)
0.909
362(91.9)
32(8.1)

133(86.4)
21(13.6)
0.050* 0.048*
Hyponatremia
 No
 Yes

215(88.8)
27(11.2)

48(92.3)
4(7.7)
0.460
357(90.6)
37(9.4)

122(79.2)
32(20.8)
0.001* 0.001*
Hypocalcemia
 No
 Yes

209(86.4)
33(13.6)

42(80.8)
10(19.2)
0.300
312(79.2)
82(20.8)

103(66.9)
51(33.1)
0.003 0.038*
Albumin, g/L
 ≥100
 <100

225(93.0)
17(7.0)

49(94.2)
3(5.8)
0.744
348(88.3)
46(11.7)

136(88.3)
18(11.7)
0.997
Hemoglobin, g/L
 ≥100
 <100

207(85.5)
35(14.5)

43(82.7)
9(17.3)
0.602
303(76.9)
91(23.1)

117(76.0)
37(24.0)
0.817
Tumor size 0.072 0.470
 ≤4.75 183(75.6) 33(63.5) 276(70.1) 103(66.9)
 >4.75 59(24.4) 19(26.5) 118(29.9) 51(33.1)
Histologic type
 Signet-ring cell carcinoma

40(16.5)

7(13.5)
0.609
41(10.4)

10(6.5)
0.170
 Differentiated 199(82.2) 45(86.5) 341(86.5) 142(92.2)
 Undifferentiated 3(1.3) 0(0.0) 12(3.1) 2(1.3)
Pathologic type 0.033* 0.038 0.552
 Ulcerative type 193(79.8) 48(92.3) 316(80.2) 120(77.9)
 Non-ulcerative type 49(20.2) 4(7.7) 78(19.8) 34(22.1)
TNM stage 0.062 0.018*
 0/I 89(36.8) 11(21.2) 129(32.7) 38(24.7)
 II 36(14.9) 7(13.5) 67(17.0) 18(11.7)
 III 117(48.3) 34(65.3) 198(50.3) 98(63.6)
N stage
 N0
 N1
 N2
 N3

114(47.1)
30(12.4)
43(17.8)
55(22.7)

18(34.6)
6(11.5)
8(15.4)
20(38.5)
0.121
176(44.7)
51(12.9)
65(16.5)
102(25.9)

54(35.1)
24(15.6)
32(20.8)
44(28.5)
0.217
T stage
 Tis/1
 T2
 T3
 T4

58(24.0)
50(20.7)
46(19.0)
88(36.3)

5(9.6)
10(19.2)
10(19.2)
26(50)
0.162
83(21.1)
91(23.1)
79(20.1)
141(35.7)

19(12.3)
32(20.8)
30(19.5)
73(47.4)
0.034*
Tumor location 0.156 0.246
 Cardia 29(12.0) 11(21.2) 83(21.1) 32(20.8)
 Corpus 55(22.7) 8(15.4) 86(21.8) 44(28.6)
 Pylorus 157(64.9) 32(61.5) 223(56.6) 76(49.4)
 Total 1(0.4) 1(1.9) 2(0.5) 2(1.2)
Anastomotic method 0.284 0.005*
 Billroth I 146(60.3) 26(50) 224(56.9) 67(43.5)
 Billroth II 41(16.9) 9(17.3) 67(17.0) 26(16.9)
 Roux-en-y 55(22.7) 17(32.7) 103(26.1) 61(39.6)
Total gastrectomy
 No
 Yes

199(82.2)
43(17.8)

39(75.0)
13(25.0)
0.228
316(80.2)
78(19.8)

103(66.9)
51(33.1)
0.001*
Combined operation 0.445 0.142
 No 226(93.4) 47(90.4) 355(85.0) 132(85.7)
 Yes 16(6.6) 5(9.6) 39(15.0) 22(14.3)
Surgical method
 Open
 Laparoscopic

212(87.6)
30(12.4)

51(98.1)
1(1.9)
0.026*
348(88.3)
46(11.7)

143(92.9)
11(7.1)
0.118

Note: *Statistically significant (P< 0.05).

Abbreviations: BMI, body mass index; TNM, Tumor-Lymph, Node, Metastasis.